Clinical trial
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in…
NCT00335205 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00335205 |
|---|---|
| Title | A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. |
| Official title | A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression. |
| Lead sponsor | Sheba Medical Center, Other |
| Collaborators | Jerusalem Mental Health Center |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | ropinirole |
| Enrollment | 60 |
| Start date | Apr 1, 2003 |
| First posted | Jun 9, 2006 |
| Last update posted | Jun 9, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: